Rare diseases
Investigational molecules
Locations
Hindenburgstrasse 50, Innenstadt, 91054 Erlangen, Germany
Research activity focuses on early breast cancer with hormone receptor positivity and HER2 negativity, particularly cases with a higher risk of recurrence and the need for closer long-term disease control.
The sponsor is also involved in studies examining treatment persistence and outcomes in patients receiving endocrine-based and targeted approaches for this disease setting.
Institut fuer Frauengesundheit GmbH runs clinical trials in conditions such as Breast cancer, Hormone receptor positive HER2 negative breast cancer, Breast cancer female, Hormone receptor positive breast cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyGermanyGermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
